Nordimet is indicated for the treatment of:


- active rheumatoid arthritis in adult patients,


- polyarthritic forms of severe, active juvenile idiopathic   arthritis (JIA), when the response to nonsteroidal

anti-inflammatory drugs (NSAIDs) has been inadequate,


- severe recalcitrant disabling psoriasis, which is not adequately responsive to other forms of therapy such as phototherapy, psoralens and ultraviolet A (PUVA), and retinoids,


- severe psoriatic arthritis in adult patients.


- Induction of remission in moderate

steroid-dependent Crohn's disease in

adult patients, in combination with

corticosteroids and for maintenance of

remission, as monotherapy, in patients

who have responded to methotrexate.


Privacy Statement

 Terms of Use

Contact Us

IE/21/NOR/005-01      Date of Prep:  Aug 2021